Category: Eaton
-
Psychedelic Weekly Roundup with MNMD.Q, MSET.C, MYND.C, MEDI.NE, AWKN.NE, SILO, MCUR.C, NOVA.C, TRYP.C, TPIA, NEON.C
Another busy week in the psychedelic sector, with many smaller companies not always covered here at Equity Guru making news. Let’s start with the biggest players though. Mind Medicine (MNMD.Q, MMED.NE) MindMed announced that they have agreed to partner with Forian (FORA.Q), who provide evidence-based support for clinical and commercial decision making. Forian and MindMed will collaborate to…
-
Psyched for this weeks news from CYBN.NE, PSYC.C, MNMD.Q, MSET.C, FTRP.Q, MYCO.NE, RVV.C, FH.NE, CMND.C, ATAI.Q
This week, news from the psychedelic sector has been dominated by patent applications and earnings being released. Here’s the run down of this week’s news. Cybin (CYBN.NE) It’s been a busy week for Cybin. Last week, after market close, they released their financials for the quarter ending on June 30, 2021, which showed they had…
-
Filament Health (FH.NE) releases financials for Q2 of 2021, Tom Kineshanko transitioning from President to Founding Advisor
Filament Health (FH.NE) to release their unaudited financial results for the second quarter of 2021, a period that ended June 30, 2021. As of June 30, Filament had $7.8 million in cash and cash equivalents. This includes $5 million which was raised through a private placement that closed on June 21. That private placement included…
-
Filament Health (FH.NE): the natural psychedelic company flying under the radar
For the vast majority of the history of human use of psychedelics, they have been seen as something sacred, a gift from God or mother nature herself. Ayahuasca, which contains DMT, was given out by shamans in the Amazon as a tea. It was a spiritual experience that would purge you of your negative energy…
-
Flashback: FansUnite (FANS.C) closes upsized $24.7 million growth capital financing
Originally posted July 16, 2021 FansUnite Entertainment (FANS.C) announced the closing of their public offering, which raised gross proceeds of $24,792,390. FANS issued 27,547,100 units for the offering, which they sold at $0.90 a piece. Each unit consisted of one share and one-half of a common share warrant. Every full warrant allows its holder to…
-
Marvel Discovery (MARV.V) finds visible gold at Blackfly Gold Project
Marvel Discovery (MARV.V) reported progress on the drilling taking place at their Blackfly Gold Project, finding visible gold. Marvel has completed 9 diamond drills completed to date for 1,116.25m; the drilling has been concentrated around the historical shaft area of their project, with 4 holes drilled at the Blackfly Northeast Zone. The historical shaft was…
-
Manganese X (MN.V) advances Battery Hill PEA
Manganese X Energy (MN.V) announced they are completing, together with Kemetco Research, test work for the Preliminary Economic Assessment (PEA) of their Battery Hill project. The Battery Hill project is located in New Brunswick, near the American border, and is one of the largest manganese resources in North America. The project has a measured and…
-
Cybin (CYBN.NE) gets final approval to list on NYSE American and announces public offering
Cybin (CYBN.NE) announced that they have received final approval from the New York Stock Exchange (NYSE) to list its shares on the NYSE American exchange. Beginning next Thursday, on August 5, 2021, Cybin will begin trading on the NYSE American under the ticker “CYBN”. Cybin will continue to trade on the NEO exchange, also under…
-
Sixth Wave (SIXW.C) completes DFM and begins delivery of first Affinity System to AESI
Sixth Wave Innovations (SIXW.C) announced that they have completed the initial Design for Manufacturing (DFM) of their Affinity System. They also announced that they commissioned the delivery of the first system to Advanced Extraction Systems Inc. (AESI) in Charlottetown, PEI, and has given AESI approval of the design and bill of materials. The Affinity system…
-
XPhyto (XPHY.C) partner will begin sale of rapid Covid-ID Lab tests in Germany next week
XPhyto Therapeutics (XPHY.C) announced their partner Max Pharma GmbH will begin to sell XPhyto’s rapid point-of-care Covid-19 PCR test system (Covid-ID Lab) in Germany next week. The Covid-ID Lab test provides quality testing for the Covid-19 virus, achieving a 95% confidence interval, and delivering results within 25 minutes. Covid-ID Lab is registered within the European…